{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:35:15Z","timestamp":1648892115416},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T00:00:00Z","timestamp":1333152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11255-012-0157-5","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T08:50:43Z","timestamp":1333097443000},"page":"1135-1144","source":"Crossref","is-referenced-by-count":3,"title":["Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels?"],"prefix":"10.1007","volume":"44","author":[{"given":"Hulya","family":"Taskapan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"key":"157_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y et al (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"157_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M et al (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421\u2013432","journal-title":"Matrix Biol"},{"key":"157_CR3","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez OM (2010) Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \u201ctrade-off\u201d hypothesis. Clin J Am Soc Nephrol 5(9):1710\u20131716 (Epub 2010 May 27)","DOI":"10.2215\/CJN.02640310"},{"key":"157_CR4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ki.2008.218","volume":"74","author":"F Memon","year":"2008","unstructured":"Memon F, El-Abbadi M, Nakatani T, Taguchi T, Lanske B, Razzaque MS (2008) Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism? Kidney Int 74:566\u2013570","journal-title":"Kidney Int"},{"key":"157_CR5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molmed.2006.05.002","volume":"12","author":"MS Razzaque","year":"2006","unstructured":"Razzaque MS, Lanske B (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 12:298\u2013305","journal-title":"Trends Mol Med"},{"key":"157_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","volume":"26","author":"M Hesse","year":"2007","unstructured":"Hesse M, Frohlich LF, Zeitz U, Lanske B, Erben RG (2007) Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 26:75\u201384","journal-title":"Matrix Biol"},{"key":"157_CR7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.05-5432fje","volume":"20","author":"MS Razzaque","year":"2006","unstructured":"Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20:720\u2013722","journal-title":"FASEB J"},{"key":"157_CR8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/clinchem\/40.3.435","volume":"40","author":"R Vieth","year":"1994","unstructured":"Vieth R (1994) Simple method for determining specific binding capacity of vitamin D binding protein and its use to calculate the concentration of \u2018free\u2019 1,25 dihydroxyvitamin D. Clin Chem 40:435\u2013441","journal-title":"Clin Chem"},{"key":"157_CR9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI111246","volume":"73","author":"AM Parfitt","year":"1984","unstructured":"Parfitt AM, Mathews CHE, Brommage R, Jarnagin K, DeLuca HF (1984) Calcitriol but no other metabolite of vitamin D is essential for growth and development in the rat. J Clin Invest 73:576\u2013586","journal-title":"J Clin Invest"},{"key":"157_CR10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1126\/science.684411","volume":"201","author":"HL Henry","year":"1978","unstructured":"Henry HL, Norman AW (1978) Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science 201:835\u2013837","journal-title":"Science"},{"key":"157_CR11","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jn\/113.12.2505","volume":"113","author":"AW Norman","year":"1983","unstructured":"Norman AW, Leathers V, Bishop JE (1983) Normal egg hatchability requires the simultaneous administration to the hen of 1a,25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol. J Nutr 113:2505\u20132515","journal-title":"J Nutr"},{"key":"157_CR12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/en.137.6.2254","volume":"137","author":"I Nemere","year":"1996","unstructured":"Nemere I (1996) Apparent nonnuclear regulation of intestinal phosphate transport: effects of 1,25 dihydroxyvitamin D3,24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3. Endocrinology 137:2254\u20132261","journal-title":"Endocrinology"},{"key":"157_CR13","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1359\/jbmr.1999.14.9.1543","volume":"14","author":"I Nemere","year":"1999","unstructured":"Nemere I (1999) 24,25-Dihydroxyvitamin D3 suppresses the rapid actions of 1,25-dihydroxyvitamin D3 and parathyroid hormone on calcium transport in chick intestine. J Bone Miner Res 14:1543\u20131549","journal-title":"J Bone Miner Res"},{"key":"157_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcb.10246","volume":"86","author":"B Zhao","year":"2002","unstructured":"Zhao B, Nemere I (2002) 1,25(OH)2D3-mediated phosphate uptake in isolated chick intestinal cells: effect of 24,25(OH)2D3, signal transduction activators, and age. J Cell Biochem 86:497\u2013508","journal-title":"J Cell Biochem"},{"key":"157_CR15","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/jcb.21008","volume":"99","author":"I Nemere","year":"2006","unstructured":"Nemere I, Wilson C, Jensen W, Steinbeck M, Rohe B, Farach-Carson MC (2006) Mechanism of 24,25-dihydroxyvitamin D3-mediated inhibition of rapid, 1,25-dihydroxyvitamin D3-induced responses: role of reactive oxygen species. J Cell Biochem 99:1572\u20131581","journal-title":"J Cell Biochem"},{"key":"157_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gcen.1995.1150","volume":"100","author":"D Larsson","year":"1995","unstructured":"Larsson D, Bjornsson BT, Sundell K (1995) Physiological concentrations of 24,25-dihydroxyvitamin D3 rapidly decrease the in vitro intestinal calcium uptake in the Atlantic cod, Gadus morhua. Gen Comp Endocrinol 100:211\u2013217","journal-title":"Gen Comp Endocrinol"},{"issue":"2","key":"157_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.steroids.2006.11.004","volume":"72","author":"RC Khanal","year":"2007","unstructured":"Khanal RC, Smith NM, Nemere I (2007) Phosphate uptake in chick kidney cells: effects of 1,25(OH)2D3 and 24,25(OH)2D3. Steroids 72(2):158\u2013164","journal-title":"Steroids"},{"key":"157_CR18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1210\/en.136.2.402","volume":"136","author":"Z Schwartz","year":"1995","unstructured":"Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD (1995) Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype character-istic of growth zone chondrocytes. Endocrinology 136:402\u2013411","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"157_CR19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jsbmb.2010.03.057","volume":"121","author":"BD Boyan","year":"2010","unstructured":"Boyan BD, Hurst-Kennedy J, Denison TA, Schwartz Z (2010) 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha,25(OH)2D3 in hypertrophic cells. J Steroid Biochem Mol Biol 121(1\u20132):212\u2013216","journal-title":"J Steroid Biochem Mol Biol"},{"key":"157_CR20","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1210\/en.137.6.2633","volume":"137","author":"T Ono","year":"1996","unstructured":"Ono T, Tanaka H, Yamate T, Nagai Y, Nakamura T, Seino Y (1996) 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Endocrinology 137:2633\u20132637","journal-title":"Endocrinology"},{"key":"157_CR21","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/en.138.9.3864","volume":"138","author":"E-G Seo","year":"1997","unstructured":"Seo E-G, Einhorn TA, Norman AW (1997) 24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 138:3864\u20133872","journal-title":"Endocrinology"},{"key":"157_CR22","first-page":"181","volume":"3","author":"JE Bishop","year":"1980","unstructured":"Bishop JE, Norman AW, Coburn JW, Roberts PA, Henry HL (1980) Studies on the metabolism of calciferol. Determination of the concentration of 25- hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in a single two milliliter plasma sample. J Miner Electrolyte Metab 3:181\u2013189","journal-title":"J Miner Electrolyte Metab"},{"issue":"1\u20132","key":"157_CR23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2010.11.005","volume":"88","author":"KR Wehmeier","year":"2011","unstructured":"Wehmeier KR, Alamir AR, Sultan S, Haas MJ, Wong NC, Mooradian AD (2011) 24, 25-dihydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A-I gene expression. Life Sci 88(1\u20132):110\u2013116","journal-title":"Life Sci"},{"key":"157_CR24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.69.7.1673","volume":"69","author":"M Garabedian","year":"1972","unstructured":"Garabedian M, Holick MF, Deluca HF, Boyle IT (1972) Control of 25 hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci USA 69:1673\u20131676","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"157_CR25","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1073\/pnas.241516798","volume":"98","author":"C Zierold","year":"2001","unstructured":"Zierold C, Mings JA, DeLuca HF (2001) Parathyroid hormone regulates 25-hydroxyvitamin D3\u201324-hydroxylase mRNA by altering its stability. Proc Natl Acad Sci USA 98(24):13572\u201313576","journal-title":"Proc Natl Acad Sci USA"},{"key":"157_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20041799","volume":"390","author":"Y Inoue","year":"2005","unstructured":"Inoue Y, Segawa H, Kaneko I, Yamanaka S, Kusano K, Kawakami E, Furutani J, Ito M, Kuwahata M, Saito H, Fukushima N, Kato S, Kanayama HO, Miyamoto K (2005) Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 390:325\u2013331","journal-title":"Biochem J"},{"key":"157_CR27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1006\/bbrc.1997.6541","volume":"233","author":"S Wu","year":"1997","unstructured":"Wu S, Grieff M, Brown AJ (1997) Regulation of renal vitamin D-24-hydroxylase by phosphate: effects of hypophysectomy, growth hormone and insulin-like growth factor I. Biochem Biophys Res Commun 233:813\u2013817","journal-title":"Biochem Biophys Res Commun"},{"issue":"6124","key":"157_CR28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/bmj.1.6124.1382","volume":"1","author":"JA Kanis","year":"1978","unstructured":"Kanis JA, Cundy T, Bartlett M, Smith R, Heynen G, Warner GT, Russell RG (1978) Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? Br Med J 1(6124):1382\u20131386","journal-title":"Br Med J"},{"issue":"4","key":"157_CR29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.1980.tb03399.x","volume":"13","author":"RS Mason","year":"1980","unstructured":"Mason RS, Lissner D, Wilkinson M, Posen S (1980) Vitamin D metabolites and their relationship to azotaemic osteodystrophy. Clin Endocrinol (Oxf) 13(4):375\u2013385","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"157_CR30","first-page":"358","volume":"11","author":"CR Dunstan","year":"1985","unstructured":"Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P et al (1985) Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Miner Electrolyte Metab 11(6):358\u2013368","journal-title":"Miner Electrolyte Metab"},{"issue":"6","key":"157_CR31","first-page":"292","volume":"24","author":"R Diemen-Steenvoorde van","year":"1985","unstructured":"van Diemen-Steenvoorde R, Donckerwolcke RA, Bosch R, Visser WJ, Raymakers JA, Duursma SA (1985) Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3. Clin Nephrol 24(6):292\u2013299","journal-title":"Clin Nephrol"},{"issue":"4","key":"157_CR32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(86)90815-6","volume":"80","author":"BM Piraino","year":"1986","unstructured":"Piraino BM, Rault R, Greenberg A, Dominguez JH, Wallia R, Houck P, Segre GV, Chen T, Foti FM, Puschett JB (1986) Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations. Am J Med 80(4):607\u2013615","journal-title":"Am J Med"},{"issue":"3","key":"157_CR33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000186437","volume":"58","author":"D Ben-Ezer","year":"1991","unstructured":"Ben-Ezer D, Shany S, Conforty A, Rapoport J, Edelstein S, Bdolah-Abram T, Kafka DR, Chaimovitz C (1991) Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients. Nephron 58(3):283\u2013287","journal-title":"Nephron"},{"issue":"3","key":"157_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000186767","volume":"60","author":"Z Varghese","year":"1992","unstructured":"Varghese Z, Moorhead JF, Farrington K (1992) Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. Nephron 60(3):286\u2013291","journal-title":"Nephron"},{"key":"157_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1440-1797.1996.tb00114.x","volume":"2","author":"JJ Kazama","year":"1996","unstructured":"Kazama JJ, Wa MF, Yi H, Kumagai M, Yamato H, Taniguchi N, Gejyo F, Arakawa M, Ozawa H, Kurokawa K (1996) 24R, 25-Dihydroxyvitamin D3 ameliorates the high-turnover bone diseases without suppressing parathyroid function in chronic renal failure in rats. Nephrology 2:361\u2013366","journal-title":"Nephrology"},{"key":"157_CR36","doi-asserted-by":"crossref","unstructured":"Birkenh\u00e4ger-Frenkel DH, Pols HA, Zeelenberg J, Eijgelsheim JJ, Schot R, Nigg AL, Weimar W, Mulder PG, Birkenh\u00e4ger JC (1995) Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J Bone Miner Res10(2):197\u2013204","DOI":"10.1002\/jbmr.5650100205"},{"issue":"2","key":"157_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/8756-3282(93)90238-6","volume":"14","author":"BM Mortensen","year":"1993","unstructured":"Mortensen BM, Aarseth HP, Ganss R, Haug E, Gautvik KM, Gordeladze JO (1993) 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients. Bone 14(2):125\u2013131","journal-title":"Bone"},{"issue":"3","key":"157_CR38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","volume":"55","author":"E Ishimura","year":"1999","unstructured":"Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H (1999) Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55(3):1019\u20131027","journal-title":"Kidney Int"},{"issue":"5","key":"157_CR39","first-page":"362","volume":"53","author":"A Gal-Moscovici","year":"2000","unstructured":"Gal-Moscovici A, Rubinger D, Popovtzer MM (2000) 24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure. Clin Nephrol 53(5):362\u2013371","journal-title":"Clin Nephrol"},{"key":"157_CR40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","volume":"78","author":"CF Helvig","year":"2010","unstructured":"Helvig CF, Cuerrier D, Hosfield CM, Ireland B, Kharebov AZ, Kim JW, Ramjit NJ, Ryder K, Tabash SP, Herzenberg AM, Epps TM, Petkovich M (2010) Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney Int 78:463\u2013472","journal-title":"Kidney Int"},{"issue":"6","key":"157_CR41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/cs0730659","volume":"73","author":"MR Clements","year":"1987","unstructured":"Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH (1987) Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci 73(6):659\u2013664","journal-title":"Clin Sci"},{"issue":"1","key":"157_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2265.1992.tb02278.x","volume":"37","author":"MR Clements","year":"1992","unstructured":"Clements MR, Davies M, Hayes ME, Hickey CD, Lumb GA, Mawer EB, Adams PH (1992) The role of 1, 25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol 37(1):17\u201327","journal-title":"Clin Endocrinol"},{"issue":"4","key":"157_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/07853898909149207","volume":"21","author":"MT Nikkil\u00e4","year":"1989","unstructured":"Nikkil\u00e4 MT, Saaristo JJ (1989) Serum vitamin D metabolite concentrations in primary hyperparathyroidism. Ann Med 21(4):281\u2013283","journal-title":"Ann Med"},{"issue":"6","key":"157_CR44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00365518209168118","volume":"42","author":"C Christiansen","year":"1982","unstructured":"Christiansen C, Christensen MS, McNair P, Nielsen B, Madsbad S (1982) Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D. Scand J Clin Lab Invest 42(6):487\u2013491","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"157_CR45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5414\/CNP66247","volume":"66","author":"H Taskapan","year":"2006","unstructured":"Taskapan H, Ersoy FF, Passadakis P et al (2006) Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol Clin Nephrol 66(4):247\u2013255","journal-title":"Clin Nephrol Clin Nephrol"},{"issue":"2","key":"157_CR46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11255-006-0081-7","volume":"38","author":"H Taskapan","year":"2006","unstructured":"Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D(3) in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38(2):323\u2013329","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"157_CR47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11255-010-9813-9","volume":"43","author":"ME Bindal","year":"2011","unstructured":"Bindal ME, Taskapan H (2011) Hypovitaminosis D and insulin resistance in peritoneal dialysis patients. Int Urol Nephrol 43(2):527\u2013534","journal-title":"Int Urol Nephrol"},{"key":"157_CR48","first-page":"58","volume":"2","author":"H Taskapan","year":"2005","unstructured":"Taskapan H, Ersoy FF, Passadakis P et al (2005) Body pain during daily activities in patients on peritoneal dialysis. Dial Transplant 2:58\u201372","journal-title":"Dial Transplant"},{"issue":"2","key":"157_CR49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5414\/CN107160","volume":"76","author":"H Taskapan","year":"2011","unstructured":"Taskapan H, Baysal O, Karahan D, Durmus B, Altay Z, Ulutas O (2011) Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D deficiency. Clin Nephrol 76(2):110\u2013116","journal-title":"Clin Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-012-0157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-012-0157-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-012-0157-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T02:34:40Z","timestamp":1593916480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-012-0157-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1007\/s11255-012-0157-5","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,31]]}}}